Biochemical and pharmacological development of steroidal inhibitors of aromatase

Androstenedione analogs containing 7 alpha-substituents have proven to be potent inhibitors of aromatase both in vitro and in vivo. Several of these agents have exhibited higher affinity for the enzyme complex than the substrate. In order to examine further the interaction(s) of 7-substituted steroids with aromatase, biochemical and pharmacological studies were performed on 7 alpha-thiosubstituted androstenediones and 7-substituted 4,6-androstadiene-3,17-diones. Potent inhibition of aromatase activity in human placental microsomes has been observed with several new 7 alpha-thiosubstituted androstenediones. 7-Benzyl- and 7-phenethyl-4,6-androstadiene-3,17-diones effectively inhibited microsomal aromatase, with apparent Kis ranging from 61 to 174 nM. On the other hand, 7-phenyl-4,6-androstadiene-3,17-dione exhibited poor activity, with an apparent Ki of 1.42 microM. Similar inhibitory activity was observed with reconstituted, purified cytochrome P450Arom preparations. Additionally, these agents were evaluated for inhibition of aromatase activity in two human carcinoma cell lines, the MCF-7 human mammary cancer line and the JAr choriocarcinoma line. The 7 alpha-thiosubstituted androstenediones and 7-substituted 4,6-androstadiene-3,17-diones produced dose-dependent inhibitions of aromatase activity in the cell cultures. The most effective inhibitors were the 7 alpha-substituted androstenediones, with EC50 values ranging from 7.3 to 105 nM. Finally, the JAr cell culture system exhibited prolonged inhibition of aromatase activity following exposure to 7 alpha-APTADD, suggesting enzyme inactivation by this inhibitor. Thus, these agents are effective aromatase inhibitors, and the results encourage further development of this group of medicinal agents for the treatment of estrogen-dependent mammary carcinoma.

[1]  W. McGuire,et al.  MCF-7: A human breast cancer cell line with estrogen, androgen, progesterone, and glucocorticoid receptors , 1975, Steroids.

[2]  J. Kellis,et al.  Purification and characterization of human placental aromatase cytochrome P-450. , 1987, The Journal of biological chemistry.

[3]  W. Cleland,et al.  The statistical analysis of enzyme kinetic data. , 1967, Advances in enzymology and related areas of molecular biology.

[4]  B. Metcalf,et al.  Time-dependent inhibition of aromatase in trophoblastic tumor cells in tissue culture. , 1984, Journal of steroid biochemistry.

[5]  P K Li,et al.  Synthesis and biochemical studies of 7-substituted 4,6-androstadiene-3,17-diones as aromatase inhibitors. , 1990, Journal of medicinal chemistry.

[6]  H. Brodie,et al.  Studies on the mechanism of estrogen biosynthesis. 8. The development of inhibitors of the enzyme system in human placenta. , 1973, Endocrinology.

[7]  R. Brueggemeier,et al.  7α-SUBSTITUTED DERIVATIVES OF ANDROSTENEDIONE AS INHIBITORS OF ESTROGEN BIOSYNTHESIS , 1985 .

[8]  R. Brueggemeier,et al.  A photoaffinity inhibitor of aromatase , 1982, Steroids.

[9]  R. Brueggemeier,et al.  Covalent modification of aromatase by a radiolabeled irreversible inhibitor. , 1985, Journal of steroid biochemistry.

[10]  R. Pattillo,et al.  Independent dibutyryl cyclic adenosine monophosphate stimulation of human chorionic gonadotropin and estrogen secretion by malignant trophoblast cells in vitro. , 1974, The Journal of clinical endocrinology and metabolism.

[11]  R. Hussa,et al.  Estrogen synthetase in choriocarcinoma cell culture. stimulation by dibutyryl cyclic adenosine monophosphate and theophylline , 1978, Steroids.

[12]  R. Brueggemeier,et al.  Effects of the aromatase inhibitor 7 alpha-(4'-amino)phenylthio-4-androstene-3,17-dione on 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma in rats. , 1988, Cancer research.

[13]  D. Covey,et al.  Comparative studies of aromatase inhibitors in cultured human breast cancer cells. , 1982, Cancer research.

[14]  R. Brueggemeier,et al.  Potent enzyme-activated inhibition of aromatase by a 7 alpha-substituted C19 steroid. , 1987, The Journal of biological chemistry.

[15]  R. Brueggemeier,et al.  Synthesis and biochemistry of fluorescent aromatase inhibitors , 1990, Steroids.

[16]  R. Brueggemeier,et al.  Effects of the aromatase inhibitor 7 alpha-(4'-amino)phenylthio-4-androstene-3,17-dione in MCF-7 human mammary carcinoma cell culture. , 1987, Cancer research.

[17]  C. Tsai-Morris,et al.  Inactivation of aromatase in vitro by 4-hydroxy-4-androstene-3,17-dione and 4-acetoxy-4-androstene-3,17-dione and sustained effects in vivo , 1981, Steroids.

[18]  R. Brueggemeier,et al.  7 α -Substituted androstenediones as effective in vttro and in vivo inhibitors of aromatase , 1987, Steroids.

[19]  W. McGuire,et al.  Estrogen control of progesterone receptor in human breast cancer: role of estradiol and antiestrogen. , 1978, Endocrinology.

[20]  R. Brueggemeier,et al.  Synthesis and biochemical evaluation of inhibitors of estrogen biosynthesis. , 1978, Journal of medicinal chemistry.

[21]  D. Covey,et al.  Enzyme-generated intermediates derived from 4-androstene-3,6,17-trione and 1,4,6-androstatriene-3,17-dione cause a time-dependent decrease in human placental aromatase activity. , 1981, Endocrinology.

[22]  H. Schut,et al.  Oestrogen formation from C19 precursors in human choriocarcinoma in culture. , 1977, Acta endocrinologica.

[23]  J. MacIndoe.  Estradiol formation from testosterone by continuously cultured human breast cancer cells. , 1979, The Journal of clinical endocrinology and metabolism.

[24]  D. Covey,et al.  Aromatase enzyme catalysis is involved in the potent inhibition of estrogen biosynthesis caused by 4-acetoxy- and 4-hydroxy-4-androstene-3, 17-dione. , 1982, Molecular pharmacology.

[25]  R. Brueggemeier,et al.  7 alpha-substituted derivatives of androstenedione as inhibitors of estrogen biosynthesis. , 1985, Journal of medicinal chemistry.

[26]  M. Lippman,et al.  The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture. , 1976, Cancer research.